We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week
Published in Benign Hematology

Journal Scan / Research · February 11, 2021

Monitoring and Management of Coagulopathy Following Tisagenlecleucel CAR T-Cell Therapy

Blood advances

 

Additional Info

Blood advances
Practical Guidelines for Monitoring and Management of Coagulopathy Following Tisagenlecleucel CAR T-Cell Therapy
Blood Adv 2021 Jan 26;5(2)593-601, J Buechner, SA Grupp, H Hiramatsu, DT Teachey, S Rives, TW Laetsch, GA Yanik, P Wood, R Awasthi, L Yi, A Chassot-Agostinho, LK Eldjerou, B De Moerloose

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading